89. リンパ脈管筋腫症 Lymphangioleiomyomatosis Clinical trials / Disease details

臨床試験数 : 38 / 薬物数 : 38 - (DrugBank : 15) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 118

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00490789 (ClinicalTrials.gov)	October 2005	21/6/2007	Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM	A Trial of the Efficacy and Safety of Sirolimus(Rapamycin)Therapy for Renal Angiomyolipmoas in Patients With Tuberous Sclerosis Complex and Sporadic Lymphangioleiomyomatosis	Tuberous Sclerosis;Lymphangioleiomyomatosis	Drug: sirolimus	Cardiff University	University of Nottingham;St Georges Hospital Medical School;Royal Sussex County Hospital;The Tuberous Sclerosis Association;Wyeth is now a wholly owned subsidiary of Pfizer	Active, not recruiting	18 Years	65 Years	Both	14	Phase 2	United Kingdom
2	NCT00457808 (ClinicalTrials.gov)	December 2002	6/4/2007	Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM	Rapamycin Therapy of Angiomyolipomas in Patients With Tuberous Sclerosis Complex and Sporadic Lymphangioleiomyomatosis	Tuberous Sclerosis;Lymphangioleiomyomatosis	Drug: Rapamycin , sirolimus	Children's Hospital Medical Center, Cincinnati	The LAM Foundation;Tuberous Sclerosis Alliance	Completed	18 Years	65 Years	Both	25	Phase 2	United States